Terumo Blood and Cell Technologies (Terumo BCT) has signed a memorandum of understanding (MOU) with the Osong Medical Innovation Foundation (KBIOHealth) to jointly develop workforce training for cell and gene therapy (CGT) manufacturing. The partnership aims to create training programs focused on mesenchymal stem cell (MSC) and chimeric antigen (CAR) T-cell therapies, utilizing Terumo BCT’s…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here